LBRX · Categories · Form 4

LBRX - SEC Form 4 insider transactions

LB Pharmaceuticals Inc (LBRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LBRX

• 3d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Nussbaum Ran

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Luse Rebecca

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Lenz Robert A.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Kane William P Jr

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 3d
  SEC Form 4 filed by Director Garland J. Scott

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 90d
  SEC Form 4 filed by Director Lenz Robert A.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 118d
  SEC Form 4 filed by Large owner Deep Track Biotechnology Master Fund, Ltd.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 179d
  SEC Form 4 filed by Chief Commercial Officer Pai Panandiker Kaya Kamlesh

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 251d
  SEC Form 4 filed by Senior Vice President, Finance Panoff Marc L

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Luse Rebecca

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Kane William P Jr

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Prensky Zachary

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Chief Business Officer Soffer Gad

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Chief Executive Officer Turner Heather D

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Chief Medical Officer Eramo Anna

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Garland J. Scott

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by Director Nussbaum Ran

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 269d
  SEC Form 4 filed by SVP, Technical Operations Silva Richard Anthony

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)

Other LBRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends